Global Gabapentin Capsules Market Research Report 2023

1 Gabapentin Capsules Market Overview
1.1 Product Overview and Scope of Gabapentin Capsules
1.2 Gabapentin Capsules Segment by Type
1.2.1 Global Gabapentin Capsules Market Value Comparison by Type (2023-2029)
1.2.2 100mg
1.2.3 300mg
1.2.4 400mg
1.3 Gabapentin Capsules Segment by Application
1.3.1 Global Gabapentin Capsules Market Value by Application: (2023-2029)
1.3.2 Epilepsy
1.3.3 Neuropathic Pain
1.3.4 Others
1.4 Global Gabapentin Capsules Market Size Estimates and Forecasts
1.4.1 Global Gabapentin Capsules Revenue 2018-2029
1.4.2 Global Gabapentin Capsules Sales 2018-2029
1.4.3 Global Gabapentin Capsules Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Gabapentin Capsules Market Competition by Manufacturers
2.1 Global Gabapentin Capsules Sales Market Share by Manufacturers (2018-2023)
2.2 Global Gabapentin Capsules Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Gabapentin Capsules Average Price by Manufacturers (2018-2023)
2.4 Global Gabapentin Capsules Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Gabapentin Capsules, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gabapentin Capsules, Product Type & Application
2.7 Gabapentin Capsules Market Competitive Situation and Trends
2.7.1 Gabapentin Capsules Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Gabapentin Capsules Players Market Share by Revenue
2.7.3 Global Gabapentin Capsules Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Gabapentin Capsules Retrospective Market Scenario by Region
3.1 Global Gabapentin Capsules Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Gabapentin Capsules Global Gabapentin Capsules Sales by Region: 2018-2029
3.2.1 Global Gabapentin Capsules Sales by Region: 2018-2023
3.2.2 Global Gabapentin Capsules Sales by Region: 2024-2029
3.3 Global Gabapentin Capsules Global Gabapentin Capsules Revenue by Region: 2018-2029
3.3.1 Global Gabapentin Capsules Revenue by Region: 2018-2023
3.3.2 Global Gabapentin Capsules Revenue by Region: 2024-2029
3.4 North America Gabapentin Capsules Market Facts & Figures by Country
3.4.1 North America Gabapentin Capsules Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Gabapentin Capsules Sales by Country (2018-2029)
3.4.3 North America Gabapentin Capsules Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Gabapentin Capsules Market Facts & Figures by Country
3.5.1 Europe Gabapentin Capsules Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Gabapentin Capsules Sales by Country (2018-2029)
3.5.3 Europe Gabapentin Capsules Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gabapentin Capsules Market Facts & Figures by Country
3.6.1 Asia Pacific Gabapentin Capsules Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Gabapentin Capsules Sales by Country (2018-2029)
3.6.3 Asia Pacific Gabapentin Capsules Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Gabapentin Capsules Market Facts & Figures by Country
3.7.1 Latin America Gabapentin Capsules Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Gabapentin Capsules Sales by Country (2018-2029)
3.7.3 Latin America Gabapentin Capsules Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gabapentin Capsules Market Facts & Figures by Country
3.8.1 Middle East and Africa Gabapentin Capsules Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Gabapentin Capsules Sales by Country (2018-2029)
3.8.3 Middle East and Africa Gabapentin Capsules Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Gabapentin Capsules Sales by Type (2018-2029)
4.1.1 Global Gabapentin Capsules Sales by Type (2018-2023)
4.1.2 Global Gabapentin Capsules Sales by Type (2024-2029)
4.1.3 Global Gabapentin Capsules Sales Market Share by Type (2018-2029)
4.2 Global Gabapentin Capsules Revenue by Type (2018-2029)
4.2.1 Global Gabapentin Capsules Revenue by Type (2018-2023)
4.2.2 Global Gabapentin Capsules Revenue by Type (2024-2029)
4.2.3 Global Gabapentin Capsules Revenue Market Share by Type (2018-2029)
4.3 Global Gabapentin Capsules Price by Type (2018-2029)
5 Segment by Application
5.1 Global Gabapentin Capsules Sales by Application (2018-2029)
5.1.1 Global Gabapentin Capsules Sales by Application (2018-2023)
5.1.2 Global Gabapentin Capsules Sales by Application (2024-2029)
5.1.3 Global Gabapentin Capsules Sales Market Share by Application (2018-2029)
5.2 Global Gabapentin Capsules Revenue by Application (2018-2029)
5.2.1 Global Gabapentin Capsules Revenue by Application (2018-2023)
5.2.2 Global Gabapentin Capsules Revenue by Application (2024-2029)
5.2.3 Global Gabapentin Capsules Revenue Market Share by Application (2018-2029)
5.3 Global Gabapentin Capsules Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Gabapentin Capsules Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Pfizer Gabapentin Capsules Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Assertio
6.2.1 Assertio Corporation Information
6.2.2 Assertio Description and Business Overview
6.2.3 Assertio Gabapentin Capsules Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Assertio Gabapentin Capsules Product Portfolio
6.2.5 Assertio Recent Developments/Updates
6.3 TEVA
6.3.1 TEVA Corporation Information
6.3.2 TEVA Description and Business Overview
6.3.3 TEVA Gabapentin Capsules Sales, Revenue and Gross Margin (2018-2023)
6.3.4 TEVA Gabapentin Capsules Product Portfolio
6.3.5 TEVA Recent Developments/Updates
6.4 Mylan
6.4.1 Mylan Corporation Information
6.4.2 Mylan Description and Business Overview
6.4.3 Mylan Gabapentin Capsules Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Mylan Gabapentin Capsules Product Portfolio
6.4.5 Mylan Recent Developments/Updates
6.5 Azurity Pharmaceuticals
6.5.1 Azurity Pharmaceuticals Corporation Information
6.5.2 Azurity Pharmaceuticals Description and Business Overview
6.5.3 Azurity Pharmaceuticals Gabapentin Capsules Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Azurity Pharmaceuticals Gabapentin Capsules Product Portfolio
6.5.5 Azurity Pharmaceuticals Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Gabapentin Capsules Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Novartis Gabapentin Capsules Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 Apotex
6.6.1 Apotex Corporation Information
6.6.2 Apotex Description and Business Overview
6.6.3 Apotex Gabapentin Capsules Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Apotex Gabapentin Capsules Product Portfolio
6.7.5 Apotex Recent Developments/Updates
6.8 Sun Pharmaceutical
6.8.1 Sun Pharmaceutical Corporation Information
6.8.2 Sun Pharmaceutical Description and Business Overview
6.8.3 Sun Pharmaceutical Gabapentin Capsules Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Sun Pharmaceutical Gabapentin Capsules Product Portfolio
6.8.5 Sun Pharmaceutical Recent Developments/Updates
6.9 Aurobindo Pharma
6.9.1 Aurobindo Pharma Corporation Information
6.9.2 Aurobindo Pharma Description and Business Overview
6.9.3 Aurobindo Pharma Gabapentin Capsules Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Aurobindo Pharma Gabapentin Capsules Product Portfolio
6.9.5 Aurobindo Pharma Recent Developments/Updates
6.10 Intas
6.10.1 Intas Corporation Information
6.10.2 Intas Description and Business Overview
6.10.3 Intas Gabapentin Capsules Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Intas Gabapentin Capsules Product Portfolio
6.10.5 Intas Recent Developments/Updates
6.11 Amneal
6.11.1 Amneal Corporation Information
6.11.2 Amneal Gabapentin Capsules Description and Business Overview
6.11.3 Amneal Gabapentin Capsules Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Amneal Gabapentin Capsules Product Portfolio
6.11.5 Amneal Recent Developments/Updates
6.12 Marksans Pharma
6.12.1 Marksans Pharma Corporation Information
6.12.2 Marksans Pharma Gabapentin Capsules Description and Business Overview
6.12.3 Marksans Pharma Gabapentin Capsules Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Marksans Pharma Gabapentin Capsules Product Portfolio
6.12.5 Marksans Pharma Recent Developments/Updates
6.13 Glenmark
6.13.1 Glenmark Corporation Information
6.13.2 Glenmark Gabapentin Capsules Description and Business Overview
6.13.3 Glenmark Gabapentin Capsules Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Glenmark Gabapentin Capsules Product Portfolio
6.13.5 Glenmark Recent Developments/Updates
6.14 Alkem
6.14.1 Alkem Corporation Information
6.14.2 Alkem Gabapentin Capsules Description and Business Overview
6.14.3 Alkem Gabapentin Capsules Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Alkem Gabapentin Capsules Product Portfolio
6.14.5 Alkem Recent Developments/Updates
6.15 Jiangsu Nhwa Pharmaceutical
6.15.1 Jiangsu Nhwa Pharmaceutical Corporation Information
6.15.2 Jiangsu Nhwa Pharmaceutical Gabapentin Capsules Description and Business Overview
6.15.3 Jiangsu Nhwa Pharmaceutical Gabapentin Capsules Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Jiangsu Nhwa Pharmaceutical Gabapentin Capsules Product Portfolio
6.15.5 Jiangsu Nhwa Pharmaceutical Recent Developments/Updates
6.16 Jiangsu Hengrui Pharmaceuticals
6.16.1 Jiangsu Hengrui Pharmaceuticals Corporation Information
6.16.2 Jiangsu Hengrui Pharmaceuticals Gabapentin Capsules Description and Business Overview
6.16.3 Jiangsu Hengrui Pharmaceuticals Gabapentin Capsules Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Jiangsu Hengrui Pharmaceuticals Gabapentin Capsules Product Portfolio
6.16.5 Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gabapentin Capsules Industry Chain Analysis
7.2 Gabapentin Capsules Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gabapentin Capsules Production Mode & Process
7.4 Gabapentin Capsules Sales and Marketing
7.4.1 Gabapentin Capsules Sales Channels
7.4.2 Gabapentin Capsules Distributors
7.5 Gabapentin Capsules Customers
8 Gabapentin Capsules Market Dynamics
8.1 Gabapentin Capsules Industry Trends
8.2 Gabapentin Capsules Market Drivers
8.3 Gabapentin Capsules Market Challenges
8.4 Gabapentin Capsules Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Gabapentin Capsules Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Gabapentin Capsules Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Gabapentin Capsules Market Competitive Situation by Manufacturers in 2022
Table 4. Global Gabapentin Capsules Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Gabapentin Capsules Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Gabapentin Capsules Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Gabapentin Capsules Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Gabapentin Capsules Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Gabapentin Capsules, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Gabapentin Capsules, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Gabapentin Capsules, Product Type & Application
Table 12. Global Key Manufacturers of Gabapentin Capsules, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Gabapentin Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gabapentin Capsules as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Gabapentin Capsules Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Gabapentin Capsules Sales by Region (2018-2023) & (K Units)
Table 18. Global Gabapentin Capsules Sales Market Share by Region (2018-2023)
Table 19. Global Gabapentin Capsules Sales by Region (2024-2029) & (K Units)
Table 20. Global Gabapentin Capsules Sales Market Share by Region (2024-2029)
Table 21. Global Gabapentin Capsules Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Gabapentin Capsules Revenue Market Share by Region (2018-2023)
Table 23. Global Gabapentin Capsules Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Gabapentin Capsules Revenue Market Share by Region (2024-2029)
Table 25. North America Gabapentin Capsules Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Gabapentin Capsules Sales by Country (2018-2023) & (K Units)
Table 27. North America Gabapentin Capsules Sales by Country (2024-2029) & (K Units)
Table 28. North America Gabapentin Capsules Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Gabapentin Capsules Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Gabapentin Capsules Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Gabapentin Capsules Sales by Country (2018-2023) & (K Units)
Table 32. Europe Gabapentin Capsules Sales by Country (2024-2029) & (K Units)
Table 33. Europe Gabapentin Capsules Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Gabapentin Capsules Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Gabapentin Capsules Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Gabapentin Capsules Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Gabapentin Capsules Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Gabapentin Capsules Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Gabapentin Capsules Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Gabapentin Capsules Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Gabapentin Capsules Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Gabapentin Capsules Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Gabapentin Capsules Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Gabapentin Capsules Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Gabapentin Capsules Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Gabapentin Capsules Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Gabapentin Capsules Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Gabapentin Capsules Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Gabapentin Capsules Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Gabapentin Capsules Sales (K Units) by Type (2018-2023)
Table 51. Global Gabapentin Capsules Sales (K Units) by Type (2024-2029)
Table 52. Global Gabapentin Capsules Sales Market Share by Type (2018-2023)
Table 53. Global Gabapentin Capsules Sales Market Share by Type (2024-2029)
Table 54. Global Gabapentin Capsules Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Gabapentin Capsules Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Gabapentin Capsules Revenue Market Share by Type (2018-2023)
Table 57. Global Gabapentin Capsules Revenue Market Share by Type (2024-2029)
Table 58. Global Gabapentin Capsules Price (US$/Unit) by Type (2018-2023)
Table 59. Global Gabapentin Capsules Price (US$/Unit) by Type (2024-2029)
Table 60. Global Gabapentin Capsules Sales (K Units) by Application (2018-2023)
Table 61. Global Gabapentin Capsules Sales (K Units) by Application (2024-2029)
Table 62. Global Gabapentin Capsules Sales Market Share by Application (2018-2023)
Table 63. Global Gabapentin Capsules Sales Market Share by Application (2024-2029)
Table 64. Global Gabapentin Capsules Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Gabapentin Capsules Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Gabapentin Capsules Revenue Market Share by Application (2018-2023)
Table 67. Global Gabapentin Capsules Revenue Market Share by Application (2024-2029)
Table 68. Global Gabapentin Capsules Price (US$/Unit) by Application (2018-2023)
Table 69. Global Gabapentin Capsules Price (US$/Unit) by Application (2024-2029)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Gabapentin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Pfizer Gabapentin Capsules Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Assertio Corporation Information
Table 76. Assertio Description and Business Overview
Table 77. Assertio Gabapentin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Assertio Gabapentin Capsules Product
Table 79. Assertio Recent Developments/Updates
Table 80. TEVA Corporation Information
Table 81. TEVA Description and Business Overview
Table 82. TEVA Gabapentin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. TEVA Gabapentin Capsules Product
Table 84. TEVA Recent Developments/Updates
Table 85. Mylan Corporation Information
Table 86. Mylan Description and Business Overview
Table 87. Mylan Gabapentin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Mylan Gabapentin Capsules Product
Table 89. Mylan Recent Developments/Updates
Table 90. Azurity Pharmaceuticals Corporation Information
Table 91. Azurity Pharmaceuticals Description and Business Overview
Table 92. Azurity Pharmaceuticals Gabapentin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Azurity Pharmaceuticals Gabapentin Capsules Product
Table 94. Azurity Pharmaceuticals Recent Developments/Updates
Table 95. Novartis Corporation Information
Table 96. Novartis Description and Business Overview
Table 97. Novartis Gabapentin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Novartis Gabapentin Capsules Product
Table 99. Novartis Recent Developments/Updates
Table 100. Apotex Corporation Information
Table 101. Apotex Description and Business Overview
Table 102. Apotex Gabapentin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. Apotex Gabapentin Capsules Product
Table 104. Apotex Recent Developments/Updates
Table 105. Sun Pharmaceutical Corporation Information
Table 106. Sun Pharmaceutical Description and Business Overview
Table 107. Sun Pharmaceutical Gabapentin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Sun Pharmaceutical Gabapentin Capsules Product
Table 109. Sun Pharmaceutical Recent Developments/Updates
Table 110. Aurobindo Pharma Corporation Information
Table 111. Aurobindo Pharma Description and Business Overview
Table 112. Aurobindo Pharma Gabapentin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Aurobindo Pharma Gabapentin Capsules Product
Table 114. Aurobindo Pharma Recent Developments/Updates
Table 115. Intas Corporation Information
Table 116. Intas Description and Business Overview
Table 117. Intas Gabapentin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Intas Gabapentin Capsules Product
Table 119. Intas Recent Developments/Updates
Table 120. Amneal Corporation Information
Table 121. Amneal Description and Business Overview
Table 122. Amneal Gabapentin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Amneal Gabapentin Capsules Product
Table 124. Amneal Recent Developments/Updates
Table 125. Marksans Pharma Corporation Information
Table 126. Marksans Pharma Description and Business Overview
Table 127. Marksans Pharma Gabapentin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Marksans Pharma Gabapentin Capsules Product
Table 129. Marksans Pharma Recent Developments/Updates
Table 130. Glenmark Corporation Information
Table 131. Glenmark Description and Business Overview
Table 132. Glenmark Gabapentin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Glenmark Gabapentin Capsules Product
Table 134. Glenmark Recent Developments/Updates
Table 135. Alkem Corporation Information
Table 136. Alkem Description and Business Overview
Table 137. Alkem Gabapentin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Alkem Gabapentin Capsules Product
Table 139. Alkem Recent Developments/Updates
Table 140. Jiangsu Nhwa Pharmaceutical Corporation Information
Table 141. Jiangsu Nhwa Pharmaceutical Description and Business Overview
Table 142. Jiangsu Nhwa Pharmaceutical Gabapentin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Jiangsu Nhwa Pharmaceutical Gabapentin Capsules Product
Table 144. Jiangsu Nhwa Pharmaceutical Recent Developments/Updates
Table 145. Jiangsu Hengrui Pharmaceuticals Corporation Information
Table 146. Jiangsu Hengrui Pharmaceuticals Description and Business Overview
Table 147. Jiangsu Hengrui Pharmaceuticals Gabapentin Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Jiangsu Hengrui Pharmaceuticals Gabapentin Capsules Product
Table 149. Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Gabapentin Capsules Distributors List
Table 153. Gabapentin Capsules Customers List
Table 154. Gabapentin Capsules Market Trends
Table 155. Gabapentin Capsules Market Drivers
Table 156. Gabapentin Capsules Market Challenges
Table 157. Gabapentin Capsules Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Gabapentin Capsules
Figure 2. Global Gabapentin Capsules Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Gabapentin Capsules Market Share by Type in 2022 & 2029
Figure 4. 100mg Product Picture
Figure 5. 300mg Product Picture
Figure 6. 400mg Product Picture
Figure 7. Global Gabapentin Capsules Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Gabapentin Capsules Market Share by Application in 2022 & 2029
Figure 9. Epilepsy
Figure 10. Neuropathic Pain
Figure 11. Others
Figure 12. Global Gabapentin Capsules Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Gabapentin Capsules Market Size (2018-2029) & (US$ Million)
Figure 14. Global Gabapentin Capsules Sales (2018-2029) & (K Units)
Figure 15. Global Gabapentin Capsules Average Price (US$/Unit) & (2018-2029)
Figure 16. Gabapentin Capsules Report Years Considered
Figure 17. Gabapentin Capsules Sales Share by Manufacturers in 2022
Figure 18. Global Gabapentin Capsules Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Gabapentin Capsules Players: Market Share by Revenue in 2022
Figure 20. Gabapentin Capsules Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Gabapentin Capsules Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Gabapentin Capsules Sales Market Share by Country (2018-2029)
Figure 23. North America Gabapentin Capsules Revenue Market Share by Country (2018-2029)
Figure 24. United States Gabapentin Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Gabapentin Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Gabapentin Capsules Sales Market Share by Country (2018-2029)
Figure 27. Europe Gabapentin Capsules Revenue Market Share by Country (2018-2029)
Figure 28. Germany Gabapentin Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Gabapentin Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Gabapentin Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Gabapentin Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Gabapentin Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Gabapentin Capsules Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Gabapentin Capsules Revenue Market Share by Region (2018-2029)
Figure 35. China Gabapentin Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Gabapentin Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Gabapentin Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Gabapentin Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Gabapentin Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. China Taiwan Gabapentin Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Southeast Asia Gabapentin Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Latin America Gabapentin Capsules Sales Market Share by Country (2018-2029)
Figure 43. Latin America Gabapentin Capsules Revenue Market Share by Country (2018-2029)
Figure 44. Mexico Gabapentin Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Brazil Gabapentin Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Argentina Gabapentin Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Gabapentin Capsules Sales Market Share by Country (2018-2029)
Figure 48. Middle East & Africa Gabapentin Capsules Revenue Market Share by Country (2018-2029)
Figure 49. Turkey Gabapentin Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Gabapentin Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. UAE Gabapentin Capsules Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Global Sales Market Share of Gabapentin Capsules by Type (2018-2029)
Figure 53. Global Revenue Market Share of Gabapentin Capsules by Type (2018-2029)
Figure 54. Global Gabapentin Capsules Price (US$/Unit) by Type (2018-2029)
Figure 55. Global Sales Market Share of Gabapentin Capsules by Application (2018-2029)
Figure 56. Global Revenue Market Share of Gabapentin Capsules by Application (2018-2029)
Figure 57. Global Gabapentin Capsules Price (US$/Unit) by Application (2018-2029)
Figure 58. Gabapentin Capsules Value Chain
Figure 59. Gabapentin Capsules Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed

Your Name

Your E-mail

Your message

Submit